Fair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
24.4%/yr
±6.9% · revenue growth to justify current price
FCF-Based Reverse DCF
27.8%/yr
±3.4% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockEcolab Inc.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
ECL delivered ~$16B in FY2025 revenue as a global leader in water, hygiene, and infection prevention. The data center water treatment vector is emerging as a material growth driver alongside biopharma...